807 filings
Page 4 of 41
424B3
ALIM
Alimera Sciences Inc.
1 Aug 23
Prospectus supplement
4:47pm
EFFECT
ALIM
Alimera Sciences Inc.
12 Jul 23
Notice of effectiveness
12:00am
424B3
ALIM
Alimera Sciences Inc.
12 Jul 23
Prospectus supplement
12:00am
UPLOAD
ALIM
Alimera Sciences Inc.
10 Jul 23
Letter from SEC
12:00am
CORRESP
ALIM
Alimera Sciences Inc.
10 Jul 23
Correspondence with SEC
12:00am
S-3
ALIM
Alimera Sciences Inc.
Shelf registration
30 Jun 23
5:12pm
DEF 14A
ALIM
Alimera Sciences Inc.
Definitive proxy
29 Jun 23
5:23pm
8-K
ALIM
Alimera Sciences Inc.
29 Jun 23
Departure of Directors or Certain Officers
5:19pm
PRE 14A
ALIM
Alimera Sciences Inc.
Preliminary proxy
15 Jun 23
12:54pm
8-K
ALIM
Alimera Sciences Inc.
9 Jun 23
Other Events
9:23am
D/A
ALIM
Alimera Sciences Inc.
31 May 23
$81.00 mm in equity / options / securities to be acquired, sold $81.00 mm, 16 investors
4:13pm
3
Velan Capital Holdings LLC
19 May 23
ALIMERA SCIENCES / BALAJI VENKATARAMAN ownership change
5:20pm
4
ALIM
Alimera Sciences Inc.
19 May 23
ALIMERA SCIENCES / Adam Morgan ownership change
5:17pm
4
Jason M. Werner
19 May 23
ALIMERA SCIENCES / Jason M. Werner ownership change
4:18pm
3
Jason M. Werner
19 May 23
ALIMERA SCIENCES / Jason M. Werner ownership change
4:10pm
SC 13D/A
Velan Capital Investment Management LP
19 May 23
ALIMERA SCIENCES / Velan Capital Investment Management ownership change
4:00pm
SC 13D/A
ALIM
Alimera Sciences Inc.
18 May 23
ALIMERA SCIENCES / Caligan Partners ownership change
5:24pm
8-K
ALIM
Alimera Sciences Inc.
18 May 23
Expected to be immediately accretive to revenue and Adjusted EBITDA in 2023
4:55pm
8-K
ALIM
Alimera Sciences Inc.
15 May 23
Alimera Sciences Reports First Quarter 2023 Results
9:05am
10-Q
2023 Q1
ALIM
Alimera Sciences Inc.
Quarterly report
15 May 23
6:51am